Top Page
Bluglass
(Sydney:BLG)
Bluglass (BLG) vs. iShares MSCI Australia ETF (EWA)
Bluglass Business Overview & Revenue Model
Bluglass Financial Statement Overview
| Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.73M | 4.62M | 1.15M | 604.75K | 363.57K | 655.83K |
| Gross Profit | 3.06M | 2.55M | -11.84M | -10.22M | -7.94M | -6.59M |
| EBITDA | -6.90M | -7.29M | -7.50M | -6.68M | -4.00M | -4.76M |
| Net Income | -10.18M | -10.14M | -11.75M | -9.36M | -6.30M | -5.99M |
Balance Sheet | ||||||
| Total Assets | 16.46M | 23.14M | 21.70M | 20.46M | 13.56M | 16.43M |
| Cash, Cash Equivalents and Short-Term Investments | 3.81M | 5.57M | 4.26M | 5.35M | 4.18M | 5.43M |
| Total Debt | 3.23M | 4.68M | 4.49M | 4.63M | 3.51M | 1.72M |
| Total Liabilities | 6.57M | 8.25M | 7.81M | 7.24M | 6.05M | 4.04M |
| Stockholders Equity | 9.90M | 14.89M | 13.89M | 13.22M | 7.51M | 12.39M |
Cash Flow | ||||||
| Free Cash Flow | -7.11M | -8.42M | -12.48M | -10.53M | -4.90M | -6.04M |
| Operating Cash Flow | -6.35M | -6.95M | -11.88M | -6.26M | -4.81M | -4.36M |
| Investing Cash Flow | -767.05K | -1.47M | -681.82K | -4.28M | -90.10K | -1.68M |
| Financing Cash Flow | 8.20M | 9.73M | 11.47M | 11.67M | 3.64M | 5.35M |
Bluglass Technical Analysis
Bluglass Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | AU$110.10M | 12.03 | 12.90% | 3.31% | 23.66% | -7.71% | |
63 Neutral | $33.80B | 5.84 | -11.67% | 1.84% | 5.28% | -18.34% | |
58 Neutral | AU$293.51M | ― | ― | 31.98% | -5.15% | ||
50 Neutral | $55.64M | ― | -92.68% | ― | ― | -37.93% | |
44 Neutral | $25.67M | ― | -106.02% | ― | 240.09% | 30.49% | |
41 Neutral | $400.81M | ― | -133.28% | ― | 72.47% | 20.08% | |
39 Underperform | AU$388.70M | ― | -46.55% | ― | 905.48% | 10.02% |
Bluglass Corporate Events
Bluglass Limited has announced the issuance of 9,230,769 unquoted securities, set to expire on May 31, 2026, with an exercise price of $0.013. This issuance is part of previously announced transactions and is not intended to be quoted on the ASX, indicating a strategic financial maneuver that may impact the company’s capital structure and stakeholder interests.
Bluglass Limited has announced the issuance of unquoted equity securities, specifically options expiring on May 31, 2026, at an exercise price of $0.013. This issuance, totaling over 173 million options, is part of the company’s strategic financial maneuvers, potentially impacting its capital structure and providing liquidity for future growth initiatives.
Bluglass Limited announced the quotation of 153,846,154 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of July 1, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and stakeholder interests positively.
BluGlass Limited has announced a change in the director’s interest notice concerning James Walker. The company disclosed that Walker, through Burrill Skies Pty Limited, has acquired 846,154 fully paid ordinary shares and an equal number of options exercisable at $0.013, expiring on May 31, 2026. This acquisition was part of a placement approved by shareholders, indicating a strategic move to potentially strengthen the company’s financial position and align director interests with shareholder value.
Bluglass Limited has announced the issuance of 391,793,079 unquoted equity securities in the form of options, set to expire on May 31, 2026. This move is part of the company’s strategic efforts to enhance its financial flexibility and support its ongoing growth initiatives in the semiconductor industry.
Bluglass Limited has announced the quotation of 391,793,079 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of June 24, 2025. This move is part of previously announced transactions and reflects the company’s ongoing efforts to enhance its market presence and operational capacity.
BluGlass Limited has issued 3,384,616 new fully paid ordinary shares at an issue price of $0.013 per share under a placement announced on May 1, 2025. This issuance was conducted without disclosure to investors under Part 6D.2 of the Corporations Act, and BluGlass confirms compliance with relevant provisions of the Act, indicating transparency and adherence to regulatory standards.
Bluglass Limited has announced the issuance of 180,845,544 unquoted equity securities in the form of options, set to expire on May 31, 2026. This issuance is part of a previously announced transaction and reflects the company’s strategic efforts to enhance its financial flexibility and support its ongoing projects in semiconductor technology.
Bluglass Limited has announced the quotation of 3,384,616 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of June 24, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the company’s financial flexibility and visibility in the market.
BluGlass Limited has successfully closed its Share Purchase Plan, raising $5.3 million, which, combined with a prior $2.3 million placement, totals $7.6 million. The funds will be used to accelerate production and delivery of its visible GaN lasers, fulfill contracts, and support additional fab equipment and working capital. The capital raised is crucial for BluGlass to enhance its laser capabilities and convert its growing project pipeline, valued at US$90-$100 million, into long-term revenues. The company’s strategic partnerships, including those with the US and Indian Departments of Defense, highlight its strong industry positioning and potential for enabling next-generation applications.
Bluglass Limited announced a proposed issue of securities, including options expiring in 2026 and 2028, as part of a placement or other type of issue. This move is likely aimed at raising capital to support the company’s operations and strategic initiatives, potentially impacting its market position and offering new opportunities for stakeholders.
BluGlass Limited has issued a supplementary prospectus to update its previous offer, extending the closing date and refreshing timelines for the quotation of new shares and options. The company has secured a commitment from a new investor to acquire additional shares if the total raised is less than $6 million, ensuring financial stability and supporting its strategic initiatives. This move is expected to bolster BluGlass’s market position and provide additional capital for its ongoing projects.
BluGlass Limited has extended the closing date for its Share Purchase Plan (SPP) Offer to accommodate additional institutional shortfall commitments, securing an extra $1.5 million. The funds will accelerate production and delivery of BluGlass’ GaN lasers, supporting new and existing contracts, and enhancing the company’s operational capacity and market positioning.
Bluglass Limited has announced a proposed issue of securities, specifically 19,500,000 piggyback options with an exercise price of $0.019, set to expire on May 31, 2028. This move is part of a placement or other type of issue, with the proposed issue date set for June 17, 2025, potentially impacting the company’s market positioning and stakeholder interests.
BluGlass Limited announced that all resolutions were passed by shareholders at their recent General Meeting. This outcome supports the company’s strategic initiatives, including the ratification and approval of share placements and options, which are expected to strengthen BluGlass’s financial position and support its growth in the photonics industry.
BluGlass Limited has announced an extension to the closing date of its Share Purchase Plan (SPP) Offer to ensure all eligible shareholders have ample time to participate. The SPP allows shareholders to purchase shares at a discounted price, with the issuance of shares and options pending shareholder approval at an upcoming general meeting. This extension reflects BluGlass’s commitment to accommodating its shareholders and may influence its market positioning by potentially increasing shareholder engagement and investment.
BluGlass Limited has become an approved supplier to the Indian Government’s Ministry of Defence, securing its first order valued at $230,000 from the Solid State Physics Laboratory. This order involves the development of gallium nitride-based laser diodes, highlighting BluGlass’s strategic partnerships and expertise in high-performance GaN laser technology. The collaboration positions BluGlass to support India’s technological advancements in defense applications, leveraging GaN lasers’ compact performance and stability for various advanced applications.
BluGlass Limited has announced that its General Meeting will be held on 13 June 2025, allowing shareholders to attend physically in Sydney. The company has opted to distribute the Notice of Meeting electronically, aligning with modern communication practices. This meeting is significant for stakeholders as it provides an opportunity to engage directly with the company’s leadership and participate in decision-making processes. Shareholders are encouraged to submit proxies or direct votes in advance to ensure their participation and to submit any questions by 6 June 2025.
BluGlass Limited is hosting a virtual business update webinar on 23 May 2025, where shareholders can learn about the company’s technical and commercial progress, project pipeline, and business development activities. The session will also cover the company’s capital raise and SPP offer, providing stakeholders with insights into BluGlass’ strategic direction and operational advancements.
BluGlass Limited has issued a correction to its previously released Cleansing Notice, clarifying that 177,460,928 new fully paid ordinary shares were issued on 9 May 2025, not 12 May 2025 as initially stated. This update ensures compliance with the Corporations Act and maintains transparency with stakeholders, reinforcing BluGlass’s commitment to accurate reporting and investor communication.
BluGlass Limited has issued 177,460,928 new fully paid ordinary shares at $0.013 per share under a placement announced earlier this month. This move, compliant with the Corporations Act, aims to strengthen BluGlass’s financial position and support its growth in the global photonics industry, enhancing its market presence and operational capabilities.
Bluglass Limited has announced the quotation of 177,460,928 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective May 9, 2025. This move is part of a previously announced transaction and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility of its shares.
BluGlass Limited has announced a target market determination for its new options and piggyback options, which are being offered to existing shareholders and placement participants under a prospectus dated May 1, 2025. This initiative aims to provide investors with short to medium-term investment opportunities, allowing them to exercise options and potentially benefit from the trading price of shares. The offer is subject to shareholder approval and does not include a cooling-off period, emphasizing the need for investors to consider their financial position and investment objectives before participating.
BluGlass Limited has announced a prospectus for a share purchase plan aimed at raising up to $6 million. The plan includes new shares and options, targeting eligible shareholders, placement participants, and commitment investors, with the offering considered speculative. The company will apply for official quotation of the new shares on the ASX but not for the new options or piggyback options.
Bluglass Limited has announced a proposed issue of securities, including options and ordinary shares, as part of a securities purchase plan and other placements. This move is aimed at raising capital to support the company’s ongoing projects and strategic initiatives, potentially strengthening its market position and providing opportunities for growth.
BluGlass Limited has released an investor presentation highlighting its advancements in quantum precision for visible lasers. This development positions the company at the forefront of laser technology innovation, potentially impacting its market standing and offering new opportunities for stakeholders.
BluGlass Limited has successfully secured $2.3 million through a placement to institutional and sophisticated investors and is launching a Share Purchase Plan (SPP) to raise up to $6 million. The funds will be used to enhance product delivery, support additional equipment, and provide working capital, aligning with the company’s strategy to expand its project pipeline valued at US$90-100 million. This financial boost is expected to strengthen BluGlass’s market position and support its partnerships, including those with the US Department of Defense, as it continues to innovate in the fields of quantum sensing, aerospace, and defense applications.
Bluglass Limited announced the cessation of 2,406,196 performance rights due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational targets and strategic goals.